Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes - PubMed (original) (raw)
. 2003 Aug 1;63(15):4315-21.
Affiliations
- PMID: 12907597
Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes
Hua Wang et al. Cancer Res. 2003.
Abstract
Comparison of gene expressing profiles between gliomas with different grades revealed frequent overexpression of insulin-like growth factor binding protein 2 (IGFBP2) in glioblastoma (GBM), the most advanced stage of glioma. To determine whether IGFBP2 is involved in the proliferative and invasive nature of GBM, we established stable SNB19 GBM cell lines that overexpress IGFBP2. Although there was no marked difference in the cell growth between IGFBP2 overexpressing SNB19(BP2) lines when compared with the control cells, these clones showed significantly increased invasive rates when compared with the parental or vector transfected SNB19 cells. Total RNAs from controls and SNB19(BP2) clones were used for microarray analysis to detect IGFBP2-mediated alterations in gene expression. When compared with parental or vector-transfected control cells, SNB19(BP2) cells consistently showed 3-5-fold increase in the expression of matrix metalloproteinase-2 (MMP-2) as well as other invasion related genes. Increased MMP-2 expression in SNB19(BP2) cells was subsequently confirmed by real time reverse-transcription PCR, Western blotting, and gelatin zymography. Furthermore, consistent with increased MMP-2 expression in SNB19(BP2) cells, transient transfection of a MMP-2 promoter/luciferase reporter also resulted in 3-6-fold higher luciferase activity in SNB19(BP2) cells than in parental or vector-transfected control cells. Finally, tissue microarray analysis of 68 GBM tissue specimens showed a significant correlation between the overexpression of IGFBP2 and elevated MMP-2 expression. Taken together, our data provide evidence that IGFBP2 contributes to glioma progression in part by enhancing MMP-2 gene transcription and in turn tumor cell invasion.
Similar articles
- Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, Dinh DH, Olivero WC, Gujrati M, Rao JS. Lakka SS, et al. Oncogene. 2002 Aug 15;21(36):5601-8. doi: 10.1038/sj.onc.1205646. Oncogene. 2002. PMID: 12165859 - Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.
Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS. Lakka SS, et al. Oncogene. 2004 Jun 10;23(27):4681-9. doi: 10.1038/sj.onc.1207616. Oncogene. 2004. PMID: 15122332 - Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm.
Zhang W, Wang H, Song SW, Fuller GN. Zhang W, et al. Brain Pathol. 2002 Jan;12(1):87-94. doi: 10.1111/j.1750-3639.2002.tb00425.x. Brain Pathol. 2002. PMID: 11770904 Free PMC article. Review. - Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?
Hoeflich A, Reisinger R, Lahm H, Kiess W, Blum WF, Kolb HJ, Weber MM, Wolf E. Hoeflich A, et al. Cancer Res. 2001 Dec 15;61(24):8601-10. Cancer Res. 2001. PMID: 11751371 Review. No abstract available.
Cited by
- The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
Parker BC, Annala MJ, Cogdell DE, Granberg KJ, Sun Y, Ji P, Li X, Gumin J, Zheng H, Hu L, Yli-Harja O, Haapasalo H, Visakorpi T, Liu X, Liu CG, Sawaya R, Fuller GN, Chen K, Lang FF, Nykter M, Zhang W. Parker BC, et al. J Clin Invest. 2013 Feb;123(2):855-65. doi: 10.1172/JCI67144. Epub 2013 Jan 9. J Clin Invest. 2013. PMID: 23298836 Free PMC article. - IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.
Gao S, Sun Y, Zhang X, Hu L, Liu Y, Chua CY, Phillips LM, Ren H, Fleming JB, Wang H, Chiao PJ, Hao J, Zhang W. Gao S, et al. Cancer Res. 2016 Nov 15;76(22):6543-6554. doi: 10.1158/0008-5472.CAN-16-0438. Epub 2016 Sep 22. Cancer Res. 2016. PMID: 27659045 Free PMC article. - Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3.
Suarez-Merino B, Hubank M, Revesz T, Harkness W, Hayward R, Thompson D, Darling JL, Thomas DG, Warr TJ. Suarez-Merino B, et al. Neuro Oncol. 2005 Jan;7(1):20-31. doi: 10.1215/S1152851704000596). Neuro Oncol. 2005. PMID: 15701279 Free PMC article. - IGFBP2 is overexpressed by pediatric malignant astrocytomas and induces the repair enzyme DNA-PK.
Becher OJ, Peterson KM, Khatua S, Santi MR, MacDonald TJ. Becher OJ, et al. J Child Neurol. 2008 Oct;23(10):1205-13. doi: 10.1177/0883073808321766. J Child Neurol. 2008. PMID: 18952587 Free PMC article. - IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer.
Lu H, Ai J, Zheng Y, Zhou W, Zhang L, Zhu J, Zhang H, Wang S. Lu H, et al. Cell Death Dis. 2024 Jun 25;15(6):447. doi: 10.1038/s41419-024-06843-y. Cell Death Dis. 2024. PMID: 38918360 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous